- Home
- software
- medical specialties
- cancer cells
- cancer cell
Refine by
Cancer Cell Software
10 software items found
by:Lunit Inc. based inSeoul, SOUTH KOREA
Quantifying PD-L1 positivity with AI analysis; Finding more PD-L1 positive patients; Counting every PD-L1 positive tumor cell; Complex is what AI does ...
by:Indica Labs Inc. based inAlbuquerque, NEW MEXICO (USA)
Indica Labs’ Multiplex IHC module separates up to five stains simultaneously within any cellular compartment (nucleus, cytoplasm or membrane) and can be used for a variety of IHC applications. This module is ideally suited for applications in immuno-oncology where multiple markers are required to characterize distinct immune and tumor cell populations within the tissue. Each cell is ...
by:Indica Labs Inc. based inAlbuquerque, NEW MEXICO (USA)
Indica Labs’ Highplex FL module allows for simultaneous analysis of an unlimited number of fluorescent markers in any cellular compartment – nucleus, cytoplasm, and/or membrane. With the option to define specific cell phenotypes according to marker positivity, this module is ideally suited for applications in immuno-oncology where multiple markers are required to characterize ...
by:Centaur Labs based inBoston, MASSACHUSETTS (USA)
90% of all healthcare data is medical images. Whether generated by smartphones or regulated medical imaging devices, this imaging data represents a significant opportunity for AI development. Our annotation platform enables clients to structure medical images by both classifying images and segmenting regions of ...
by:Indica Labs Inc. based inAlbuquerque, NEW MEXICO (USA)
HALO AI is a collection of train-by-example classification and segmentation tools underpinned by advanced deep learning neural network algorithms. HALO AI classifiers can be trained to quantify tissue classes, to segment tissue classes for analysis with other HALO image analysis modules, to find rare events or cells in tissues, and to categorize cell populations into specific ...
by:NEC OncoImmunity AS based inOslo, NORWAY
The NEC Immune Profiler Provides an Holistic Approach to Antigen Presentation Prediction. NEC OncoImmunity AS has developed an AI engine for its clinical projects, known as the NEC Immune Profiler, that predicts from next generation sequencing data true neoantigens for personalized cancer immunotherapy and cancer immunotherapy ...
by:Physiomics Plc based inOxford, UNITED KINGDOM
Virtual Tumour™ is our advanced, predictive modelling simulation tool used worldwide by global pharmaceuticals to small biotech companies to support oncology ...
Manufactured by:OncoDNA S.A. based inGosselies, BELGIUM
Order OncoDNA's solutions, browse your patients' history and receive your personalised report on treatment recommendations. When you join OncoSHARE, you become a member of an active network gathering together more than 13,000 patients and oncologists. Regardless of whether the information concerns patient health or payment, we take every precaution to ensure your security. OncoSHARE is used by ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Push the boundaries of your in-house liquid biopsy capabilities with MSK-ACCESS® powered with SOPHiA DDM™, a decentralized version of the rigorously validated cell-free DNA (cfDNA) assay developed and used in clinical routine by Memorial Sloan Kettering Cancer Center (MSK)1,2. Discover an innovative solution that combines MSK’s expertise in ...
by:Immunai based inNew York, NEW YORK (USA)
Immunai’s end-to-end single-cell platform enables high resolution profiling of the immune system at industrial scale, generating biological insights that accelerate R&D and power novel ...